Second EU GMP certification bolsters Company’s international export capabilities
News from Aphria
LEAMINGTON, ON, Jan. 22, 2020 /CNW/ – Aphria Inc. (“Aphria” or the “Company“) (TSX: APHA and NYSE: APHA) today announced that it has received its European Union Good Manufacturing Practices (“EU GMP“) certification as an active substance manufacturer in accordance with Art.111 of Directive 2001/83 EC from the Malta Medicines Authority (“MMA“) at the Company’s Aphria One facility in Leamington, Ontario.
This marks Aphria’s second EU GMP certified facility, following the previously announced certification at the Company’s subsidiary, ARA – Avanti Rx Analytics (“Avanti”).
“We are pleased to receive EU GMP certification for our Aphria One facility which strengthens our international export capabilities,”said Irwin D. Simon, Chief Executive Officer.
“Looking ahead, we are excited by the momentum and expect to see acceleration in terms of both sales and profitability in the second half of fiscal 2020. We continue to believe the opportunities for long-term shareholder value creation are very strong in Canada and internationally.”
As with the Company’s EU GMP certification of Avanti, Aphria selected the MMA to perform the EU GMP audit as the criteria and certification thresholds established by the MMA are among the most stringent and demanding in the EU. The certification will allow the Company’s Aphria One facility to be a supplier of bulk dried flower for medicinal use worldwide to other EU GMP certified facilities licensed to further process or package bulk dried flower into finished cannabis product for sale in permitted jurisdictions.
We Have A Good Thing Growin
For more information visit Aphria website
This article is written and published by The Cannabis Stock
Disclaimer : The Cannabis Stock wants to promote the cannabis market with the best articles and news on the market. The Cannabis Stock does not recommend selling or buying any of the company mentioned and is not responsible for any losses that may result.Reusable Block
The Cannabis Stock and its employees may from time to time own shares of the companies named in the articles. All the facts reported by the cannabis stock are information that comes directly from the companies, from their website or on Sedar and are only published as information.
Click on a star to rate this article !
Average rating / 5. Vote count:
No votes so far! Be the first to rate this post.